- $1.07bn
- $1.45bn
- $671.35m
- 84
- 51
- 38
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.68 | ||
| PEG Ratio (f) | 1.81 | ||
| EPS Growth (f) | 16.55% | ||
| Dividend Yield (f) | 2.53% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.19 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 16.3 | ||
| Price to Sales | 1.6 | ||
| EV to EBITDA | 17.75 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.01% | ||
| Return on Equity | 5.75% | ||
| Operating Margin | 9.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 422.97 | 495.02 | 553.14 | 604.8 | 671.35 | 751.35 | 795.76 | 6.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -23.41 | +22.23 | +22.02 | -22.07 | +1.79 | +19.02 | +12.1 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 775 outpatient physical therapy clinics in 43 states. Its segments include physical therapy operations and industrial injury prevention services (IIP). Its physical therapy operations segment consists of physical therapy and occupational therapy clinics that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, and sports-related injuries, and rehabilitation of injured workers. Services provided by the IIP segment include onsite services for client’s employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. These services are performed through industrial sports medicine professionals, consisting of both physical therapists and specialized certified athletic trainers.
Directors
- Edward Kuntz NEC (76)
- Christopher Reading PRE (57)
- Carey Hendrickson CFO (58)
- Eric Williams COO (55)
- Graham Reeve OTH (57)
- Anne Motsenbocker DRC (60)
- Reginald Swanson DRC (67)
- Mark Brookner IND (76)
- Harry Chapman IND (76)
- Kathleen Gilmartin IND (69)
- Bernard Harris IND (65)
- Clayton Trier IND (69)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 1st, 1992
- Public Since
- May 29th, 1992
- No. of Shareholders
- 85
- No. of Employees
- 4,034
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 15,191,689
- Address
- 1300 West Sam Houston Parkway, Suite 300, HOUSTON, 77043
- Web
- https://www.usph.com/
- Phone
- +1 7132977000
- Contact
- Carey Hendrickson
- Auditors
- Grant Thornton LLP
Upcoming Events for USPH
Q1 2025 US Physical Therapy Inc Earnings Call
US Physical Therapy Inc Annual Shareholders Meeting
Q2 2025 US Physical Therapy Inc Earnings Release
Similar to USPH
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
What is the US Physical Therapy share price?
As of Today at 23:54 UTC, shares in US Physical Therapy are trading at $70.53. This share price information is delayed by 15 minutes.
How has the US Physical Therapy share price performed this year?
Shares in US Physical Therapy last closed at $70.53 and the price had moved by -29.74% over the past 365 days. In terms of relative price strength the US Physical Therapy share price has underperformed the S&P500 Index by -35.14% over the past year.
What are the analyst and broker recommendations for US Physical Therapy?
The overall consensus recommendation for US Physical Therapy is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the US Physical Therapy dividend yield?
The US Physical Therapy dividend yield is 2.5% based on the trailing twelve month period.
Does US Physical Therapy pay a dividend?
Last year, US Physical Therapy paid a total dividend of $1.76, and it currently has a trailing dividend yield of 2.5%. We do not have any data on when US Physical Therapy is to next pay dividends.
When does US Physical Therapy next pay dividends?
We do not have data on when US Physical Therapy is to next pay dividends. The historic dividend yield on US Physical Therapy shares is currently 2.5%.
How do I buy US Physical Therapy shares?
To buy shares in US Physical Therapy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of US Physical Therapy?
As of the previous close price of $70.53, shares in US Physical Therapy had a market capitalisation of $1.07bn.
Where are US Physical Therapy shares listed?
Here are the trading details for US Physical Therapy:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: USPH
What kind of share is US Physical Therapy?
Based on an overall assessment of its quality, value and momentum US Physical Therapy is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a US Physical Therapy share price forecast for 2025?
The analyst consensus target price for shares in US Physical Therapy is $108.00. That is 53.13% above the last closing price of $70.53.
Analysts covering US Physical Therapy currently have a consensus Earnings Per Share (EPS) forecast of $2.65 for the next financial year.
Find out moreWhat is the trend in the US Physical Therapy share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like US Physical Therapy. Over the past six months, its share price has underperformed the S&P500 Index by -7.96%.
As of the last closing price of $70.53, shares in US Physical Therapy were trading -17.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the US Physical Therapy PE Ratio?
The US Physical Therapy PE ratio based on its reported earnings over the past 12 months is 25.68. The shares last closed at $70.53.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of US Physical Therapy?
US Physical Therapy's management team is headed by:
- Edward Kuntz - NEC
- Christopher Reading - PRE
- Carey Hendrickson - CFO
- Eric Williams - COO
- Graham Reeve - OTH
- Anne Motsenbocker - DRC
- Reginald Swanson - DRC
- Mark Brookner - IND
- Harry Chapman - IND
- Kathleen Gilmartin - IND
- Bernard Harris - IND
- Clayton Trier - IND